Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
53.55
+1.71 (3.30%)
At close: Oct 8, 2025, 4:00 PM EDT
53.51
-0.04 (-0.07%)
After-hours: Oct 8, 2025, 5:30 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2019 - 2020
PYLARIFY Revenue
1.03B1.06B
Log In
Log In
Log In
Upgrade
Other Radiopharmaceutical Oncology Revenue
-384.00K
Log In
Log In
Log In
Upgrade
Total Radiopharmaceutical Oncology Revenue
1.03B1.06B
Log In
Log In
Log In
Upgrade
DEFINITY Revenue
326.28M317.79M
Log In
Log In
Log In
Upgrade
TechneLite Revenue
90.28M95.49M
Log In
Log In
Log In
Upgrade
Other Precision Diagnostics Revenue
24.81M24.23M
Log In
Log In
Log In
Upgrade
Total Precision Diagnostics Revenue
441.37M437.51M
Log In
Log In
Log In
Upgrade
Strategic Partnerships and Other Revenue
45.28M38.18M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-1.48B-1.50B
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.52B1.53B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2019 - 2020
Product Revenue
1.50B1.52B
Log In
Log In
Log In
Upgrade
License and Royalty Revenue
16.48M9.13M
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.52B1.53B
Log In
Log In
Log In
Upgrade
Updated Aug 6, 2025. Data Source: Fiscal.ai.